Adagio Medical Inc.

Adagio Medical Inc. is a medical device company based in Laguna Hills, California, founded in 2011. The company is focused on improving the treatment of cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia, through innovative, minimally invasive cardiac ablation technologies. Their mission is to enhance patient outcomes by creating durable lesions in heart tissue using advanced cryoablation techniques. The company has developed unique technologies, including Ultra-Low Temperature Cryoablation (ULTC) and Pulsed Field Cryoablation (PFCA). These methods aim to provide effective alternatives to traditional surgical treatments, improving recovery times and long-term results for patients. Adagio Medical also engages in clinical studies and research collaborations to validate the safety and effectiveness of its technologies, contributing to advancements in cardiac arrhythmia treatment. Adagio Medical serves hospitals, cardiac electrophysiologists, and healthcare providers, focusing on enhancing procedural outcomes and patient care in the field of cardiac arrhythmias. The company is publicly traded on Nasdaq under the ticker symbol ADGM.

• Employees 80
• Founded 2011
• Annual Revenue $296000
• Total Funding $79137125